Iacovino, M.L.; Miceli, C.C.; De Felice, M.; Barone, B.; Pompella, L.; Chiancone, F.; Di Zazzo, E.; Tirino, G.; Della Corte, C.M.; Imbimbo, C.;
et al. Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors. Int. J. Mol. Sci. 2022, 23, 1133.
https://doi.org/10.3390/ijms23031133
AMA Style
Iacovino ML, Miceli CC, De Felice M, Barone B, Pompella L, Chiancone F, Di Zazzo E, Tirino G, Della Corte CM, Imbimbo C,
et al. Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 2022; 23(3):1133.
https://doi.org/10.3390/ijms23031133
Chicago/Turabian Style
Iacovino, Maria Lucia, Chiara Carmen Miceli, Marco De Felice, Biagio Barone, Luca Pompella, Francesco Chiancone, Erika Di Zazzo, Giuseppe Tirino, Carminia Maria Della Corte, Ciro Imbimbo,
and et al. 2022. "Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors" International Journal of Molecular Sciences 23, no. 3: 1133.
https://doi.org/10.3390/ijms23031133
APA Style
Iacovino, M. L., Miceli, C. C., De Felice, M., Barone, B., Pompella, L., Chiancone, F., Di Zazzo, E., Tirino, G., Della Corte, C. M., Imbimbo, C., De Vita, F., & Crocetto, F.
(2022). Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors. International Journal of Molecular Sciences, 23(3), 1133.
https://doi.org/10.3390/ijms23031133